References
- Ruiz-Argüelles GJ. Trombofilia. In: Ruiz-Argüelles GJ. (ed) Fundamentos de Hematologia, 3rd ed. Editorial Médica Panamericana: Mexico City, 2003; 424-436.
- Ruiz-Argüelles GJ, Gonzalez-Estrada S, Garcés-Eisele J, Ruiz-Argüelles A. Primary thrombophilia in Mexico: a prospective study. Am J Hematol 1999; 60: 1–5.
- Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ramírez-Cisneros F. Primary thrombophilia in Mexico II: factor V G1691A (Leiden), prothrombin G20210A and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Méxican mesti-zos. Am J Hematol 2001; 66: 28–31.
- Ruiz-Argüelles GJ, López-Martínez B, Cruz-Cruz D, Reyes-Aulis MB. Primary thrombophilia in México III. A prospective study of the sticky platelet syndrome. Clin Appl Thromb Hemost 2002; 8: 273–277.
- Ruiz-Argüelles GJ, Poblete-Naredo I, Reyes-Núñez V, Garcés-Eisele J, López-Martínez B, Gómez-Rangel D. Primary thrombo-philia in México IV: Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Méxican Mestizos. Rev Invest Clin Mex 2004; 56: 600–604.
- Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, Gómez-Rangel JD, Reyes-Núñez V, Garcés-Eisele J. Primary thrombophilia in México V: a comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol 2005; 78: 21–26.
- Ruiz-Argüelles GJ, González-Carrillo ML, Reyes-Nú&#xz00F1;ez V et al. Trombofilia primaria en México. Parte VI: Falta de asociaci6n estadistica entre las condiciones trombofilicas heredadas. Gac Med Mex 2007; 143: 317–322.
- Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ruiz-DelgadoGJ, Navarro-Vázquez M, Gonzalez-Carrillo M. The Janus kinase 2 (JAK2) V617F mutation in hematological malignancies in Mexico. Rev Invest Clin Méx 2006,58: 458–461.
- Goerttler PL, Marz E, Johansson PL, Andreasson B, Kutti J, Moliterno AR. MPD Research Consortium. Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels. The MPD Research Consortium. Haematologica 2005; 90: 851–853.
- Breccia M, Morano SG, D'Andrea M, Russo E, D'Elia GM, Alimena G. Budd-Chiari syndrome as the first manifestation of polycythemia vera in young women with inherited thrombophilic state: an aggressive form of myeloproliferative disorder requiring multidisciplinary management. Eur J Haematol 2005; 75: 396–400.
- De Stefano V, Teofili L, Leone G, Michiels JJ. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. Semin Thromb Hemost 1997; 23: 411–418.
- Acharya J, Westwood NB, Sawyer BM et al. Identification of latent myeloproliferative disease in patients with Budd-Chiari syndrome using X-chromosome inactivation patterns and in vitro erythroid colony formation. Eur J Haematol 1995; 55: 315–321.
- Pons-Estel BA, Catoggio U, Cardiel MH et al. The GLADEL multinational Latin American prospective inception cohort of 1214 patients with systemic lupus erythematosus. Ethnic and disease heterogeneity among 'Hispanics'. Medicine 2004; 83: 1–17.
- Baxter EJ, Scott LM, Campbell PJ et al. Cancer genome project. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061.
- Remacha AF, Estivill C, Sarda MP et al. The V617F mutation of JAK2 is very uncommon in patients with thrombosis. Haematologica 2007; 92: 285–286.
- Ruiz-Argüelles GJ, López-Martínez B, Lobato-Mendizábal E, Ruiz-Delgado GJ. An addition to geographic hematology: chronic myeloproliferative diseases are infrequent in Mexican Mestizos. Int J Hematol 2002; 75: 499–502.